These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2304345)

  • 61. Intralesional immunotherapy as a strategy to treat melanoma.
    Nouri N; Garbe C
    Expert Opin Biol Ther; 2016; 16(5):619-26. PubMed ID: 26898656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of the rabbit V-2 carcinoma with intralesional cisplatin.
    Wright KC; Carrasco CH; Wallace S; Stephens LC
    Chemotherapy; 1985; 31(1):60-7. PubMed ID: 4038641
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
    Bergman NS; Urie BK; Pardo AD; Newman RG
    J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.
    Weide B; Eigentler TK; Pflugfelder A; Zelba H; Martens A; Pawelec G; Giovannoni L; Ruffini PA; Elia G; Neri D; Gutzmer R; Becker JC; Garbe C
    Cancer Immunol Res; 2014 Jul; 2(7):668-78. PubMed ID: 24906352
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma. A biologically important observation.
    Mc Clay EF; Mc Clay ME; Albright KD; Jones JA; Christen RD; Alcaraz J; Howell SB
    Cancer; 1993 Sep; 72(6):1914-8. PubMed ID: 8364868
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A case of feline injection-site sarcoma at the site of cisplatin injections.
    Martano M; Morello E; Iussich S; Buracco P
    J Feline Med Surg; 2012 Oct; 14(10):751-4. PubMed ID: 22628268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brief intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly CODE regimen.
    Murray N; Osoba D; Shah A; Page R; Karsai H; Little C
    J Natl Cancer Inst; 1991 Feb; 83(3):190-4. PubMed ID: 1846431
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
    Miller AA; Wang XF; Gu L; Hoffman P; Khatri J; Dunphy F; Edelman MJ; Bolger M; Vokes EE; Green MR;
    J Thorac Oncol; 2008 Oct; 3(10):1159-65. PubMed ID: 18827613
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Rationale for "Laser-Induced Thermal Therapy (LITT) and Intratumoral Cisplatin" Approach for Cancer Treatment.
    de Brito RV; Mancini MW; Palumbo MDN; Moraes LHO; Rodrigues GJ; Cervantes O; Sercarz JA; Paiva MB
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682611
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice.
    Landrito JE; Yoshiga K; Sakurai K; Takada K
    Cancer Chemother Pharmacol; 1994; 34(4):323-30. PubMed ID: 8033299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.
    Taguchi T
    Clin Pharmacokinet; 1994 Apr; 26(4):275-91. PubMed ID: 8013161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice.
    Yu NY; Orenberg EK; Luck EE; Brown DM
    Cancer Chemother Pharmacol; 1995; 36(1):27-34. PubMed ID: 7720172
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intralesional cis-diamminedichloroplatinum and purified collagen treatment of human metastatic malignancies: a feasibility study.
    Krag DN; Théon AP; Schneider PD; Goodnight JE
    J Surg Oncol; 1990 Feb; 43(2):83-7. PubMed ID: 2304345
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma.
    Oratz R; Hauschild A; Sebastian G; Schadendorf D; Castro D; Bröcker EB; Orenberg EK
    Melanoma Res; 2003 Feb; 13(1):59-66. PubMed ID: 12569286
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study.
    Burris HA; Vogel CL; Castro D; Mishra L; Schwarz M; Spencer S; Oakes DD; Korey A; Orenberg EK
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):496-503. PubMed ID: 9560102
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.